Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Human FKBP5 (aa 394-407) Synthetic Peptide

Synthetic Peptide

Supplier:  Invitrogen™ PEP078

Catalog No. PEP078

Item Discontinued This item has been discontinued by the supplier. Please to view product availability in your area.

Explore available promotions

Description

Description

Human FKBP51 (residues 394-407) Synthetic Peptide, PEP-078, from Invitrogen.

PEP-078 is a 14 amino acid synthetic peptide whose sequence corresponds to residues 394-407 of human FKBP51 with a carboxy terminal cysteine added for carrier protein conjugation. The sequence of this peptide is (amino to carboxy terminus): C (394) -Q-K-K-A-K-E-H-N-E-R-D-R-R (407)This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product and human FKBP51, catalog # PA1-020. Using a solution of peptide of equal volume and concentration to the corresponding antibody will yield a large molar excess of peptide (∼70-fold) for competitive inhibition of antibody-protein binding reactions.Reconstitute with 0.1 ml of distilled water.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

2289
purified
Human FKBP5 (aa 394-407)
-20°C. Avoid freeze-thaw cycles.
Lyophilized
Control
Yes
Peptide
RUO - research use only
Human
Q13451
0.5 mg/mL
Synthetic Peptide
peptide with no preservative
FKBP5
No preservative
50 μg
C(394) -Q - K - K - A - K - E - H - N - E - R - D - R - R(407)
Product Suggestions

Product Suggestions

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.